Lasa Supergenerics cash flow

·Pharma & HealthChart ›
Latest FY26
Cash from operations
−₹22.8cr−₹2.8 cr in FY25
Capital spending
₹0.0crNo figure a year before
Free cash flow
−₹22.8cr−₹2.8 cr in FY25
Cash from financing
₹0.0cr−₹5.7 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—0.012.310.713.4
—0.00.10.00.0
—0.42.71.94.2
—0.0−0.0−0.11.8
—0.00.00.10.1
—0.00.02.20.0
Changes in working capital
—9.9−5.5−5.1−2.4
—1.52.15.316.1
—0.09.26.70.0
—0.00.0−0.10.0
—0.01.70.0−1.4
—0.0−0.10.0−0.0
—0.0−3.84.6−7.5
—0.0−2.20.31.6
—0.00.00.00.0
—0.03.40.1−1.3
—0.0−9.80.00.0
—0.06.5−6.54.1
—0.00.01.00.0
Cash from operating activities
−15.5−34.6−19.4−19.1−42.3
—11.816.621.328.6
—−22.8−2.82.1−13.7
—0.00.00.0−19.9
—0.00.00.0−0.0
—−22.8−2.82.1−33.5
Cash from investing activities
—0.00.0−0.74.8
—0.07.80.00.0
—0.00.40.21.8
—0.00.0−1.24.6
—0.08.2−0.41.5
Cash from financing activities
—0.01.80.00.0
—0.05.30.00.0
—0.02.71.9−4.2
—0.00.50.00.0
—0.0−5.7−1.94.2
—−22.8−0.3−0.2−27.8
—0.00.00.00.8
—−22.8−0.3−0.2−27.0
———0.6−16.0
Reference items
−8.7−28.46.32.2−6.6
−137.2%−113.0%4.4%2.1%−5.1%
−22.8−22.8−2.81.5−38.3
——−25.021.6—
−₹4.56−₹4.56−₹0.56₹0.29−₹7.65
—0.67×0.19×−0.10×0.87×
—0.00.00.0−0.0
——2.71.94.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

LASA₹4.67

Lasa Supergenerics Limited

· Pharma & Health
₹ CrorePeersMANGALAMBIOFILCHEMORTINGLOBEVINEETLABKREBSBIOALPABALPHARMANATCAPSUQMcap ₹23.4 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation13.410.712.30.0—
+ Impairment Loss / (Reversal)0.00.00.10.0—
+ Finance Costs4.21.92.70.4—
+ Interest Income1.8-0.1-0.00.0—
+ Other Non-cash Items0.10.10.00.0—
+ Other — Cash Effects are Investing / Financing0.02.20.00.0—
Changes in Working Capital
+ Inventories-2.4-5.1-5.59.9—
+ Trade Receivables — Current16.15.32.11.5—
+ Other Financial Assets — Current0.06.79.20.0—
+ Other Financial Assets — Non-current0.0-0.10.00.0—
+ Other Current Assets-1.40.01.70.0—
+ Other Non-current Assets-0.00.0-0.10.0—
+ Trade Payables — Current-7.54.6-3.80.0—
+ Other Financial Liabilities — Current1.60.3-2.20.0—
+ Other Financial Liabilities — Non-current0.00.00.00.0—
+ Other Current Liabilities-1.30.13.40.0—
+ Other Non-current Liabilities0.00.0-9.80.0—
+ Provisions — Current4.1-6.56.50.0—
+ Provisions — Non-current0.01.00.00.0—
Cash from Operating Activities
Profit Before Tax (per I/S)-42.3-19.1-19.4-34.6-15.5
+ Total Adjustments (incl. Working Capital)28.621.316.611.8—
Cash from Operations (pre-tax)-13.72.1-2.8-22.8—
+ Other Inflows / (Outflows) — Operating-19.90.00.00.0—
+ Income Taxes Paid-0.00.00.00.0—
Cash from Operating Activities-33.52.1-2.8-22.8—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)4.8-0.70.00.0—
+ Disp of Fixed Assets0.00.07.80.0—
+ Interest Received — Investing1.80.20.40.0—
+ Other Inflows / (Outflows) — Investing4.6-1.20.00.0—
Cash from Investing Activities1.5-0.48.20.0—
Cash from Financing Activities
+ Proceeds from Other Equity Instruments0.00.01.80.0—
+ Repayment of Borrowings0.00.05.30.0—
+ Interest Paid-4.21.92.70.0—
+ Other Inflows / (Outflows) — Financing0.00.00.50.0—
Cash from Financing Activities4.2-1.9-5.70.0—
Net Changes in Cash (pre-FX)-27.8-0.2-0.3-22.8—
+ Effect of FX Rate Changes on Cash0.80.00.00.0—
Net Changes in Cash-27.0-0.2-0.3-22.8—
Closing Cash-16.00.6———
Reference Items
EBITDA-6.62.26.3-28.4-8.7
EBITDA Margin %-5.092.084.40-112.98-137.17
Free Cash Flow (CFO − Capex)-38.31.5-2.8-22.8-22.8
Free Cash Flow to Equity—21.6-25.0——
Free Cash Flow per Basic Share-7.650.29-0.56-4.56-4.56
Cash Flow to Net Income0.87-0.100.190.67—
Cash Paid for Taxes-0.00.00.00.0—
Cash Paid for Interest4.21.92.7——
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.